Patent 11311486 was granted and assigned to Pacira Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.
Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.